{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T14:24:08Z","timestamp":1773066248070,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005969","name":"Universit\u00e0 di Bologna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005969","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jpba.2022.114876","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T11:33:36Z","timestamp":1654515216000},"page":"114876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A\u03b21-42 peptide toxicity on neuronal cells: A lipidomic study"],"prefix":"10.1016","volume":"219","author":[{"given":"Lara","family":"Davani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Montanari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"L\u00e4mmerhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenza","family":"Andrisano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2022.114876_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer\u2019s disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jpba.2022.114876_bib2","article-title":"Alzheimer\u2019s disease and the amyloid cascade hypothesis: a critical review","volume":"2012","author":"Reitz","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.jpba.2022.114876_bib3","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1073\/pnas.91.8.3270","article-title":"A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease","volume":"91","author":"Hensley","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jpba.2022.114876_bib4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cis.2013.10.015","article-title":"Probing the interplay between amyloidogenic proteins and membranes using lipid monolayers and bilayers","volume":"207","author":"Relini","year":"2014","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.jpba.2022.114876_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3389\/fncel.2019.00309","article-title":"Alzheimer\u2019s disease as a membrane disorder: spatial cross-talk among beta-amyloid peptides, nicotinic acetylcholine receptors and lipid rafts","volume":"13","author":"Fabiani","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jpba.2022.114876_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainresbull.2018.11.012","article-title":"Lipid metabolism in Alzheimer\u2019s disease","volume":"144","author":"Zhu","year":"2019","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jpba.2022.114876_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/17460441.2020.1674808","article-title":"Recent advances from metabolomics and lipidomics application in alzheimer\u2019s disease inspiring drug discovery","volume":"15","author":"Cuperlovic-Culf","year":"2020","journal-title":"Expert Opin. Drug Disco"},{"key":"10.1016\/j.jpba.2022.114876_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jpba.2016.07.008","article-title":"Metabolomics studies in brain tissue: a review","volume":"130","author":"Gonzalez-Riano","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2022.114876_bib9","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.3390\/cells10102591","article-title":"Lipid profiling of Alzheimer\u2019s disease brain highlights enrichment in glycerol(Phospho)lipid, and sphingolipid metabolism","volume":"10","author":"Akyol","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jpba.2022.114876_bib10","first-page":"303","volume":"15","author":"Zarrouk A","year":"2018","journal-title":"Lipid Biomark. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.jpba.2022.114876_bib11","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jalz.2017.01.008","article-title":"Dysregulation of lipids in Alzheimer\u2019s disease and their role as potential biomarkers","volume":"13","author":"Wong","year":"2017","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.jpba.2022.114876_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/bs.irn.2015.05.008","article-title":"Lipidomics of human brain aging and Alzheimer\u2019s disease pathology","volume":"122","author":"Naud\u00ed","year":"2015","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.jpba.2022.114876_bib13","article-title":"Plasma lipids as biomarkers for Alzheimer\u2019s disease: a systematic review","volume":"12","author":"Agarwal","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.jpba.2022.114876_bib14","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1194\/jlr.S087163","article-title":"MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines","volume":"59","author":"Burla","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jpba.2022.114876_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ab.2011.03.020","article-title":"Kinetic characterization of amyloid-beta 1-42 aggregation with a multimethodological approach","volume":"414","author":"Bartolini","year":"2011","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jpba.2022.114876_bib16","doi-asserted-by":"crossref","first-page":"12308","DOI":"10.1021\/acsomega.9b01531","article-title":"Investigating in vitro amyloid peptide 1\u221242 aggregation: Impact of higher molecular weight stable adducts","volume":"4","author":"De Simone","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.jpba.2022.114876_bib17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.aca.2019.08.030","article-title":"Comprehensive lipidomics of mouse plasma using class-specific surrogate calibrants and SWATH acquisition for large-scale lipid quantification in untargeted analysis","volume":"1086","author":"Drotleff","year":"2019","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2022.114876_bib18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nmeth.3393","article-title":"MS-DIAL: data-independent MS\/MS deconvolution for comprehensive metabolome analysis","volume":"12","author":"Tsugawa","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jpba.2022.114876_bib19","first-page":"796","article-title":"Genistein protects against amyloid-beta-induced toxicity in SH-SY5Y cells by regulation of Akt and Tau phosphorylation","volume":"34","author":"dos","year":"2019","journal-title":"Phyther. Res."},{"key":"10.1016\/j.jpba.2022.114876_bib20","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3233\/JAD-2010-091207","article-title":"Amyloid-\u03b21\u201342\u2009M induces reactive oxygen species-mediated autophagic cell death in U87 and SH-SY5Y cells","volume":"21","author":"Wang","year":"2010","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.jpba.2022.114876_bib21","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s12035-019-01733-3","article-title":"Lipid analysis of the 6-Hydroxydopamine-Treated SH-SY5Y cell model for Parkinson\u2019s disease","volume":"57","author":"Xicoy","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jpba.2022.114876_bib22","first-page":"53193","article-title":"Differentiation of the SH-SY5Y human neuroblastoma cell line","volume":"17","author":"Shipley","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jpba.2022.114876_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186636","article-title":"In situ fibrillizing amyloid-beta 1-42 induces neurite degeneration and apoptosis of differentiated SH-SY5Y cells","volume":"12","author":"Krishtal","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2022.114876_bib24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/jnr.490390404","article-title":"\u03b2\/A4\u2013evoked degeneration of differentiated SH\u2010SY5Y human neuroblastoma cells","volume":"39","author":"Lambert","year":"1994","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jpba.2022.114876_bib25","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1002\/cbic.200700427","article-title":"Insight into the kinetic of amyloid \u03b2 (1-42) peptide self-aggregation: Elucidation of inhibitors\u2019 mechanism of action","volume":"8","author":"Bartolini","year":"2007","journal-title":"ChemBioChem"},{"key":"10.1016\/j.jpba.2022.114876_bib26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.aca.2018.10.035","article-title":"Comparison of simple monophasic versus classical biphasic extraction protocols for comprehensive UHPLC-MS\/MS lipidomic analysis of Hela cells","volume":"1048","author":"Calder\u00f3n","year":"2019","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2022.114876_bib27","doi-asserted-by":"crossref","first-page":"21596","DOI":"10.1021\/acsomega.9b03463","article-title":"Fast and quantitative phospholipidomic analysis of SH-SY5Y neuroblastoma cell cultures using liquid chromatography-tandem mass spectrometry and 31P nuclear magnetic resonance","volume":"4","author":"Jakubec","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.jpba.2022.114876_bib28","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.3390\/ijms21041505","article-title":"Lipids and alzheimer\u2019s disease","volume":"21","author":"Kao","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpba.2022.114876_bib29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm.3466","article-title":"Plasma phospholipids identify antecedent memory impairment in older adults","volume":"20","author":"Mapstone","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpba.2022.114876_bib30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40478-017-0460-6","article-title":"Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A2 in a spatial-specific manner","volume":"5","author":"Palavicini","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jpba.2022.114876_bib31","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3390\/ijms14011310","article-title":"Phospholipids and Alzheimer\u2019s disease: Alterations, mechanisms and potential biomarkers","volume":"14","author":"Kosicek","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpba.2022.114876_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jnc.15025","article-title":"The lipid component of Alzheimer\u2019s disease research","volume":"154","author":"Munter","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jpba.2022.114876_bib33","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1042\/bst0320144","article-title":"Connection of lipid peroxide oxidation with the sphingomyelin pathway in the development of Alzheimer\u2019s disease","volume":"32","author":"Alessenko","year":"2004","journal-title":": Biochem. Soc. Trans."},{"key":"10.1016\/j.jpba.2022.114876_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111610","article-title":"Physiological functions and therapeutic applications of neutral sphingomyelinase and acid sphingomyelinase","volume":"139","author":"Xiang","year":"2021","journal-title":"Biomed. Pharmacother."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522002977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522002977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:22:02Z","timestamp":1760001722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708522002977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":34,"alternative-id":["S0731708522002977"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2022.114876","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A\u03b21-42 peptide toxicity on neuronal cells: A lipidomic study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2022.114876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114876"}}